• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多学科团队质量改善局部进展期直肠癌患者的生存结局:STELLAR 试验的事后分析。

Multidisciplinary team quality improves the survival outcomes of locally advanced rectal cancer patients: A post hoc analysis of the STELLAR trial.

机构信息

State Key Laboratory of Molecular Oncology and Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC), Beijing, China.

Department of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, China.

出版信息

Radiother Oncol. 2024 Nov;200:110524. doi: 10.1016/j.radonc.2024.110524. Epub 2024 Sep 5.

DOI:10.1016/j.radonc.2024.110524
PMID:39243864
Abstract

PURPOSE

We sought to determine the association between multidisciplinary team (MDT) quality and survival of patients with locally advanced rectal cancer.

METHODS

In a post hoc analysis of the randomized phase III STELLAR trial, 464 patients with distal or middle-third, clinical tumor category cT3-4 and/or regional lymph node-positive rectal cancer who completed surgery were evaluated. Disease-free survival (DFS) and Overall survival (OS) were stratified by Multidisciplinary team (MDT) quality, which was also included in the univariable and multivariable analyses of DFS and OS.

RESULTS

According to the univariable analyses, a significantly worse DFS was associated with a fewer specialized medical disciplines participating in MDT (<5 vs ≥ 5; P=0.049),a lower frequency of MDT meetings (<once a week vs ≥ once a week; P=0.021) and a smaller MDT annual discussion volume of rectal cancer (≤200 vs > 200; P=0.039). In addition, a lower number of specialized medical disciplines participating in MDT (<5 vs ≥ 5; P<0.001), a lower frequency of MDT meetings (<once a week vs ≥ once a week; P<0.001) and a smaller MDT annual discussion volume of rectal cancer (≤200 vs > 200; P=0.001) were the variables associated with OS. These 3 factors were considered when assessing MDT quality, which was classified into 2 categories: high quality or general quality. Patients treated in hospitals with high MDT quality had longer 3-year OS (90.5 % vs 78.1 %; P=0.001) and similar 3-year DFS (70.3 % vs 61.3 %; P=0.109) compared to those treated in hospitals of the general MDT quality group. Furthermore, multivariable analyses revealed a significance for DFS (HR, 1.648; 95 % CI, 1.143-2.375; P=0.007) and OS (HR, 2.771; 95 % CI, 1.575-4.877; P<0.001) in MDT quality.

CONCLUSIONS

The use of hospitals with optimized multidisciplinary infrastructure had a significant influence on survival of patients with locally advanced rectal cancer.

摘要

目的

我们旨在确定多学科团队(MDT)质量与局部晚期直肠癌患者生存之间的关系。

方法

在 STELLAR 试验的事后分析中,对完成手术的 464 名远端或中三分之一、临床肿瘤类别 cT3-4 和/或区域淋巴结阳性的直肠癌症患者进行评估。无病生存(DFS)和总生存(OS)根据多学科团队(MDT)质量进行分层,MDT 质量也包括在 DFS 和 OS 的单变量和多变量分析中。

结果

根据单变量分析,与 MDT 中参与的专业医学学科较少(<5 与≥5;P=0.049)、MDT 会议频率较低(<每周一次与≥每周一次;P=0.021)和 MDT 年度直肠癌讨论量较小(≤200 与>200;P=0.039)显著相关的 DFS 较差。此外,MDT 中参与的专业医学学科较少(<5 与≥5;P<0.001)、MDT 会议频率较低(<每周一次与≥每周一次;P<0.001)和 MDT 年度直肠癌讨论量较小(≤200 与>200;P=0.001)与 OS 相关。这些 3 个因素在评估 MDT 质量时被考虑在内,MDT 质量被分为 2 类:高质量或一般质量。在 MDT 质量较高的医院接受治疗的患者,3 年 OS 率(90.5%与 78.1%;P=0.001)较长,3 年 DFS 率(70.3%与 61.3%;P=0.109)相似,而在 MDT 质量一般的医院接受治疗的患者。此外,多变量分析显示 MDT 质量对 DFS(HR,1.648;95%CI,1.143-2.375;P=0.007)和 OS(HR,2.771;95%CI,1.575-4.877;P<0.001)有意义。

结论

使用优化的多学科基础设施的医院对局部晚期直肠癌患者的生存有显著影响。

相似文献

1
Multidisciplinary team quality improves the survival outcomes of locally advanced rectal cancer patients: A post hoc analysis of the STELLAR trial.多学科团队质量改善局部进展期直肠癌患者的生存结局:STELLAR 试验的事后分析。
Radiother Oncol. 2024 Nov;200:110524. doi: 10.1016/j.radonc.2024.110524. Epub 2024 Sep 5.
2
Number of lymph nodes retrieved in patients with locally advanced rectal cancer after total neoadjuvant therapy: post-hoc analysis from the STELLAR trial.局部进展期直肠癌患者接受全新辅助治疗后淋巴结检出数目:来自 STELLAR 试验的事后分析。
BJS Open. 2024 Sep 3;8(5). doi: 10.1093/bjsopen/zrae118.
3
Alliance A022104/NRG-GI010: The Janus Rectal Cancer Trial: a randomized phase II/III trial testing the efficacy of triplet versus doublet chemotherapy regarding clinical complete response and disease-free survival in patients with locally advanced rectal cancer.A022104/NRG-GI010 联盟:杰纳斯直肠癌试验:一项随机 II/III 期试验,旨在测试三联化疗与双联化疗在局部晚期直肠癌患者的临床完全缓解和无病生存方面的疗效。
BMC Cancer. 2024 Jul 26;24(1):901. doi: 10.1186/s12885-024-12529-7.
4
Multidisciplinary discussion and management of rectal cancer: a population-based study.直肠癌的多学科讨论和管理:一项基于人群的研究。
World J Surg. 2011 Sep;35(9):2125-33. doi: 10.1007/s00268-011-1181-9.
5
Post-hoc analysis of clinicopathological factors affecting lateral lymph node metastasis based on STELLAR study for rectal cancer.基于 STELLAR 研究对直肠癌侧方淋巴结转移的临床病理因素的事后分析。
Radiother Oncol. 2024 Nov;200:110512. doi: 10.1016/j.radonc.2024.110512. Epub 2024 Aug 30.
6
Can tumor regression grade influence survival outcome in ypT3 rectal cancer?肿瘤退缩分级会影响ypT3期直肠癌的生存结局吗?
Clin Transl Oncol. 2016 Jul;18(7):693-9. doi: 10.1007/s12094-015-1419-3. Epub 2015 Nov 2.
7
Preoperative multidisciplinary team assessment is associated with improved survival in patients with locally advanced colon cancer; a nationwide cohort study in 3157 patients.术前多学科团队评估与局部晚期结肠癌患者的生存改善相关;3157 例患者的全国性队列研究。
Eur J Surg Oncol. 2021 Sep;47(9):2398-2404. doi: 10.1016/j.ejso.2021.05.008. Epub 2021 May 14.
8
Association of Treatment Adherence With Oncologic Outcomes for Patients With Rectal Cancer: A Post Hoc Analysis of the CAO/ARO/AIO-04 Phase 3 Randomized Clinical Trial.治疗依从性与直肠癌患者肿瘤学结局的相关性:CAO/ARO/AIO-04 期随机临床试验的事后分析。
JAMA Oncol. 2020 Sep 1;6(9):1416-1421. doi: 10.1001/jamaoncol.2020.2394.
9
Induction treatment with FOLFIRINOX or oxaliplatin-based doublet followed by long-course chemoradiotherapy and surgery in locally advanced rectal cancer. A systematic review and pooled analysis from phase II and III trials.局部晚期直肠癌的 FOLFIRINOX 或奥沙利铂为基础的双联方案诱导治疗,随后进行长程放化疗和手术:来自 II 期和 III 期试验的系统评价和汇总分析。
Cancer Treat Rev. 2024 Nov;130:102829. doi: 10.1016/j.ctrv.2024.102829. Epub 2024 Sep 16.
10
Prognostic Value of Lymph Node Ratio in Locally Advanced Rectal Cancer Patients After Preoperative Chemoradiotherapy Followed by Total Mesorectal Excision.术前放化疗联合全直肠系膜切除术后局部晚期直肠癌患者淋巴结比率的预后价值
Medicine (Baltimore). 2016 Mar;95(9):e2988. doi: 10.1097/MD.0000000000002988.

引用本文的文献

1
Perforated Rectal Cancer Presenting With Symptoms of Sciatic Nerve Compression: A Case Report.以坐骨神经受压症状为表现的穿孔性直肠癌:一例报告
Case Rep Surg. 2025 Jul 22;2025:8680616. doi: 10.1155/cris/8680616. eCollection 2025.
2
Multimodal Preoperative Management of Rectal Cancer: A Review of the Existing Guidelines.直肠癌的多模式术前管理:现有指南综述
Medicina (Kaunas). 2025 Jun 24;61(7):1132. doi: 10.3390/medicina61071132.
3
Comprehensive Analysis of Factors Associated with Treatment Delays in Asian, Native Hawaiian, and Other Pacific Islander Patients with Colorectal Cancer.
对亚洲、夏威夷原住民及其他太平洋岛民结肠癌患者治疗延迟相关因素的综合分析。
J Gastrointest Cancer. 2025 Jul 19;56(1):160. doi: 10.1007/s12029-025-01279-9.
4
Guidance on the Surgical Management of Rectal Cancer: An Umbrella Review.直肠癌手术管理指南:一项伞状综述
Life (Basel). 2025 Jun 13;15(6):955. doi: 10.3390/life15060955.